1. Home
  2. CNTX vs MAMO Comparison

CNTX vs MAMO Comparison

Compare CNTX & MAMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTX
  • MAMO
  • Stock Information
  • Founded
  • CNTX 2015
  • MAMO 2008
  • Country
  • CNTX United States
  • MAMO United States
  • Employees
  • CNTX N/A
  • MAMO N/A
  • Industry
  • CNTX Biotechnology: Pharmaceutical Preparations
  • MAMO
  • Sector
  • CNTX Health Care
  • MAMO
  • Exchange
  • CNTX Nasdaq
  • MAMO NYSE
  • Market Cap
  • CNTX 78.0M
  • MAMO 91.0M
  • IPO Year
  • CNTX 2021
  • MAMO 2024
  • Fundamental
  • Price
  • CNTX $0.58
  • MAMO $2.09
  • Analyst Decision
  • CNTX Strong Buy
  • MAMO
  • Analyst Count
  • CNTX 4
  • MAMO 0
  • Target Price
  • CNTX $6.00
  • MAMO N/A
  • AVG Volume (30 Days)
  • CNTX 390.0K
  • MAMO 3.6K
  • Earning Date
  • CNTX 08-06-2025
  • MAMO 08-11-2025
  • Dividend Yield
  • CNTX N/A
  • MAMO N/A
  • EPS Growth
  • CNTX N/A
  • MAMO N/A
  • EPS
  • CNTX N/A
  • MAMO N/A
  • Revenue
  • CNTX N/A
  • MAMO $95,959,187.00
  • Revenue This Year
  • CNTX N/A
  • MAMO N/A
  • Revenue Next Year
  • CNTX N/A
  • MAMO N/A
  • P/E Ratio
  • CNTX N/A
  • MAMO N/A
  • Revenue Growth
  • CNTX N/A
  • MAMO N/A
  • 52 Week Low
  • CNTX $0.49
  • MAMO $1.84
  • 52 Week High
  • CNTX $2.75
  • MAMO $4.66
  • Technical
  • Relative Strength Index (RSI)
  • CNTX 44.00
  • MAMO N/A
  • Support Level
  • CNTX $0.56
  • MAMO N/A
  • Resistance Level
  • CNTX $0.63
  • MAMO N/A
  • Average True Range (ATR)
  • CNTX 0.08
  • MAMO 0.00
  • MACD
  • CNTX 0.00
  • MAMO 0.00
  • Stochastic Oscillator
  • CNTX 27.68
  • MAMO 0.00

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

About MAMO MASSIMO GROUP

Massimo Group is engaged in the mid-tier band the (Mid-Tier Band) of the Powersports Vehicles and Boats Industry. It manufacture, import and distribute a diversified portfolio of products divided into two main lines: a motor sports brand consisting of utility terrain vehicles (UTVs), all-terrain vehicles (ATVs), motorcycles, scooters, golf carts, and a juvenile line from go karts to balance bikes; and a motor boat line consisting of pontoon and tritoon boats (Pontoon Boats).

Share on Social Networks: